These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8339724)

  • 1. Correlation of frameshift mutagenicity with DNA intercalation by CGS 20928A using an in vitro DNA unwinding assay.
    Mattes WB; Kapeghian JC; Lasinski ER; O'Lone SD; Puri EC; Matheson DW
    Environ Mol Mutagen; 1993; 22(1):46-53. PubMed ID: 8339724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new Salmonella tester strain, TA97, for the detection of frameshift mutagens. A run of cytosines as a mutational hot-spot.
    Levin DE; Yamasaki E; Ames BN
    Mutat Res; 1982 Jun; 94(2):315-30. PubMed ID: 6125883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships for the mutagenic activity of tricyclic intercalating agents in Salmonella typhimurium.
    Denny WA; Turner PM; Atwell GJ; Rewcastle GW; Ferguson LR
    Mutat Res; 1990 Oct; 232(2):233-41. PubMed ID: 2215533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new mutagenicity assay method for frameshift mutagens based on deleting or inserting a guanosine nucleotide in the beta-lactamase gene.
    Hour TC; Lee CC; Lin JK
    Mutagenesis; 1995 Sep; 10(5):433-8. PubMed ID: 8544757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between frameshift mutagenicity and DNA-binding affinity in a series of acridine-substituted derivatives of the experimental antitumour drug 4'-(9-acridinylamino)methanesulphonanilide (AMSA).
    Ferguson LR; Baguley BC
    Mutat Res; 1981 Jun; 82(1):31-9. PubMed ID: 7022171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bleomycin amplification assay in V79 cells predicts frameshift mutagenicity of intercalative agents.
    Snyder RD; Diehl MS
    Mutagenesis; 2000 May; 15(3):203-5. PubMed ID: 10792011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA binding and growth inhibitory properties of a series of 2,7-di-alkyl-substituted derivatives of proflavine.
    Baguley BC; Ferguson LR; Denny WA
    Chem Biol Interact; 1982 Oct; 42(1):97-105. PubMed ID: 6758964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of SYBR Green I nucleic acid gel stain mutagenicity and ethidium bromide mutagenicity in the Salmonella/mammalian microsome reverse mutation assay (Ames test).
    Singer VL; Lawlor TE; Yue S
    Mutat Res; 1999 Feb; 439(1):37-47. PubMed ID: 10029672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using base-specific Salmonella tester strains to characterize the types of mutation induced by benzidine and benzidine congeners after reductive metabolism.
    Claxton LD; Hughes TJ; Chung KT
    Food Chem Toxicol; 2001 Dec; 39(12):1253-61. PubMed ID: 11696399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frameshift mutagenesis by acridines and other reversibly-binding DNA ligands.
    Ferguson LR; Denny WA
    Mutagenesis; 1990 Nov; 5(6):529-40. PubMed ID: 2263212
    [No Abstract]   [Full Text] [Related]  

  • 11. Proflavin: an unusual mutagen.
    Speck WT; Rosenkranz HS
    Mutat Res; 1980 Jan; 77(1):37-43. PubMed ID: 6987510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotoxicity of non-covalent interactions: DNA intercalators.
    Ferguson LR; Denny WA
    Mutat Res; 2007 Oct; 623(1-2):14-23. PubMed ID: 17498749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frameshift mutagenesis in Salmonella typhimurium by reversible DNA intercalators: effect of a UVR B mutation.
    René B; Auclair C; Paoletti C
    Biochem Biophys Res Commun; 1986 Jul; 138(2):505-11. PubMed ID: 3527166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of mutagenic properties in a series of DNA-directed alkylating agents by variation of chain length and alkylator reactivity.
    Ferguson LR; Turner PM; Pogai H; Denny WA
    Mutat Res; 1992 Feb; 265(2):181-93. PubMed ID: 1370717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of substituents introduced into 9-aminoacridine on frameshift mutagenicity and DNA binding affinity.
    Tomosaka H; Omata S; Hasegawa E; Anzai K
    Biosci Biotechnol Biochem; 1997 Jul; 61(7):1121-5. PubMed ID: 9255975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay of 855 test chemicals in ten tester strains using a new modification of the Ames test for bacterial mutagens.
    McMahon RE; Cline JC; Thompson CZ
    Cancer Res; 1979 Mar; 39(3):682-93. PubMed ID: 371791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of the L-arabinose forward mutation assay of Salmonella typhimurium to frameshift-type mutagens.
    Hera C; Pueyo C
    Mutat Res; 1988 Feb; 203(1):39-45. PubMed ID: 3277045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frameshift mutations: relative roles of simple intercalation and of adduct formation.
    McCoy EC; Rosenkranz EJ; Petrullo LA; Rosenkranz HS
    Mutat Res; 1981 Sep; 90(1):21-30. PubMed ID: 7029268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse correlation between bacterial frameshift mutagenicity and yeast mitochondrial effects of antitumour anilinoacridines.
    Baguley BC; Ferguson LR
    Chem Biol Interact; 1985 Dec; 56(2-3):145-55. PubMed ID: 3907865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The preparation of anthraquinone used in the National Toxicology Program cancer bioassay was contaminated with the mutagen 9-nitroanthracene.
    Butterworth BE; Mathre OB; Ballinger K
    Mutagenesis; 2001 Mar; 16(2):169-77. PubMed ID: 11230561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.